Advanced Course Online
|Join FOCIS today!
Instructions to Access Content
- Click here and click on Advanced Course in Basic & Clinical Immunology.
- Click Add to Basket on the right side of the page.
- Click on Interventional Immunology.
- If you are a FOCIS member, login with your FOCIS username and password. If you are not a member, please create an account.
- Select if you would like access to the content only, or if you would like to claim CME credit.
- After submitting the order, click on Continue to My Content.
- Select the video to watch and pause to complete the pre-test.
- Click on Submit Credit at any point to print your CME certificate. Before you can print the certificate, you will be asked to complete the post-test and evaluation.
The target audience includes clinical fellows in disciplines related to immunology, including rheumatology, allergy, infectious disease, oncology and transplantation, fellows doing basic research with an emphasis on human disease, scientists or other research and development personnel from biotechnology and pharmaceutical companies who are involved in developing new therapies for immunological disease and academic or community physicians who wish to enhance their understanding of immunology. The content of this webinar was captured during the live Advanced Course in Basic & Clinical Immunology, February 26-March 1, 2012 in Scottsdale, Arizona. The estimated time to complete this activity is 16.5 hours.
Date of Release
This activity was released on May 7, 2012. It is available for CME credit until May 7, 2015.
Upon completion of this activity, the participant should be able to:
- Discuss the fundamental mechanisms underlying protective immune responses, and discuss the recent advances and emerging themes in immunology research.
- Describe the fundamental mechanisms underlying immunologic diseases and associate these mechanisms with strategies for therapeutic modulation of the immune system.
- Appreciate the basic immunological principles underlying biotherapeutics, recognize the commonality among diverse organ specific disease states, and infer the mechanisms of therapeutic effect
- Analyze the medical literature reporting immunologic advances pertinent to their patients, cite the rationale for use of new immunodiagnostic and immunotherapeutic modalities in their patients, and to serve as thought leaders within their medical community.
- Antigen Proessing and Presentation - Andrea Sant, PhD, University of Rochester School of Medicine and Dentistry
- Leukocyte Migration - Jason Cyster, PhD, University of California, San Francisco
- The Next Generation of TNF Inhibitors - Leonard Calabrese, DO, Cleveland Clinic Foundation
- T Cell Activation and Costimulation - Abul K. Abbas, MD, University of California, San Francisco
- Cytokines and T Cell Subsets - Andrew Lichtman, MD, PhD, Brigham & Women's Hospital
- B Cell Activation and Regulation - Shiv Pillai, MD, PhD, Massachusetts General Hospital
- Tolerance and Immune Regulation - Abul K. Abbas, MD, University of California, San Francisco
- NK and NKT Cells - Lewis Lanier, PhD, University of California, San Francisco
- Autoimmunity - Mark Anderson, MD, PhD, University of California, San Francisco
- Immunodeficiency - Steven Holland, MD, National Institutes of Health/National Institute of Allergy and Infectious Diseases
- Allergic Disease - Stephen Galli, MD, Stanford University
- Transplantation - Jonathan Maltzman, MD, PhD, University of Pennsylvania
- New and Emerging Immune Therapies - Scott Plevy, MD, University of North Carolina at Chapel Hill
The Federation of Clinical Immunology Societies is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education credits for physicians.
The Federation of Clinical Immunology Societies designates this educational activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- Jason Cyster, PhD - Consultant/Advisor: Novartis
- Leonard Calabrese, DO - Consultant/Advisor & Lecture Fees: Amgen, Abbott, Centocor, UCB, Roche, Genentech
- Lewis Lanier, PhD - Consultant/advisor: Novo Nordisk, SBI Biotech
- Jonathan Maltzman, MD, PhD - Owner/equity: GlaxoSmithKline; Grant support: Amgen
- Scott Plevy, MD - Consulting fee: Abbott Immunology, Biomodels, Inc., Calcimedica, Inc., Elan Pharmaceuticals, enGene, Inc., Genentech, Janssen Biotech (formerly Centocor), Novartis, Novo Nordisk, Pharmacyclics, Prometheus Labs, Protagonist Therapeutics, Inc., Shire, Synergy Pharmaceuticals, Takeda Pharmaceuticals, Tanabe, Therakos, Inc., TransTech Pharmaceuticals, UCB; Honoraria: Abbott Immunology, Tanabe, Centocor, Inc., Salix Pharmaceuticals, Inc., UCB, Prometheus Labs
The following individuals have disclosed no financial interests/arrangements or affliation with any commercial companies who have provided products or services relating to the presentation(s) or commercial support for this continuing medical education activity:
- Abul Abbas, MD
- Mark Anderson, MD, PhD
- Richard Blumberg, MD
- Stephen Galli, MD
- Steven Holland, MD
- Andrew Lichtman, MD, PhD
- Shiv Pillai, MD, PhD
- Andrea Sant, PhD
This course was supported by unrestricted educational grants from Abbott, Amgen, Boehringer Ingelheim, Genentech, Janssen, the National Institutes of Health and Talecris.
for more information.